We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
5 hedge funds and large institutions have $57K invested in Windtree Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
5.97% more ownership
Funds ownership: 0.07% → 6.04% (+6%)
48% less capital invested
Capital invested by funds: $109K → $57K (-$51.7K)
55% less funds holding
Funds holding: 11 → 5 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
5
Holders Change
-6
Holders Change %
-54.55%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$170K |
| 2 |
Morgan Stanley
New York
|
+$92.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.93K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$610 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$142 |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$41.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20.7K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.8K |
| 4 |
Two Sigma Investments
New York
|
-$5.05K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$4.78K |